JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
JMP Securities Starts Checkpoint Software (CHKP) at Market Perform
-
Pieris Pharma (PIRS) Prices 9.1M Common Stock Offering at $2.75/Share
-
Pieris Pharmaceuticals Prices Public Offering of Common Stock
-
JMP Securities Downgrades Vitae Pharmaceuticals (VTAE) to Market Perform
-
SoTHERLY Hotels (SOHO) Prices 3M Common Stock Offering for Proceeds of $21.3M
-
SoTHERLY Hotels Inc. Announces Pricing of Common Stock Offering
-
Green Brick Partners, Inc. Announces Pricing Of Common Stock Offering
-
Unusual 11 Mid-Day Movers 6/24: (MEET) (HEAR) (CPXX) Higher; (TTHI) (DSKX) (ADHD) Lower
-
Esperion Therapeutics (ESPR) Reconfirmed Timelines for Upcoming Catalysts, JMP Securities Notes
-
Nevro Announces Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares
-
Pre-Open Stock Movers 06/23: (GDOT) (PHMD) (FIT) (DRI) Higher; (CTP) (VICL) (MELA) Lower (more...)
-
Whitestone REIT (WSR) Prices 3.75M Common Offering for Proceeds of $51.6M
-
Whitestone REIT Announces Pricing of Public Offering
-
Halyard Health, Inc. to Present at JMP Securities Life Sciences Conference
-
Stemline Therapeutics to Present at the JMP Securities Life Sciences Conference
-
Calithera Biosciences (CALA) Selects CB-1158 as Immuno-Oncology Clinical Candidate
-
Calithera Biosciences Selects Immuno-Oncology Clinical Candidate CB-1158, an Oral Arginase Inhibitor for the Treatment of Cancer
-
Calithera Biosciences Selects Immuno-Oncology Clinical Candidate CB-1158, an Oral Arginase Inhibitor for the Treatment of Cancer
-
Reitan Convenience Chooses Revionics Price Optimization and Advanced Analytics Solutions
-
After-Hours Stock Movers 06/22: (GDOT) (EXXI) (STWD) Higher; (VICL) (SONC) (GLOP) Lower (more...)
-
Green Brick Partners (GRBK) Announces 17M Common Stock Offering
-
Green Brick Partners, Inc. Announces Proposed Offering Of Common Stock
-
Whitestone REIT (WSR) Announces 3.75M Common Stock Offeirng
-
Whitestone REIT Announces Proposed Offering of Common Shares
-
Whitestone REIT Announces Proposed Offering of Common Shares
-
Unusual 11 Mid-Day Movers 6/22: (STRN) (EPZM) (UEC) Higher; (AMBA) (MSO) (MHR) Lower
-
Streetinsider.com's Hot Lunchtime Reads 6/22: (DEPO) (AAPL) (RKT) (LLY)
-
Depomed (DEPO) Moves to Session Highs Ahead of JMP Securities Life Sciences Conference Presentation
-
Notable Analyst Rating Changes 6/22: (MET) (PGR) (SNDK) Upgraded; (ALL) (SYMC) (PLCM) Downgraded
-
BIND Therapeutics (BIND) Appoints Andrew Hirsch as Permanent CEO
-
BIND Therapeutics Appoints Andrew Hirsch as President and Chief Executive Officer
-
UPDATE: JMP Securities Starts Akebia Therapeutics (AKBA) at Outperform, PT $24
-
UPDATE: JMP Securities Starts BioLineRx (BLRX) at Market Outperform
-
SoTHERLY Hotels (SOHO) Launches 3M Common Stock Offering
-
SoTHERLY Hotels Inc. Announces Launch of Offering of Common Stock
-
Progyny to Present at the 2015 JMP Securities Life Science Conference
-
Aptose Biosciences to Present at the 10th Annual JMP Securities Life Sciences Conference
-
LoanCore Realty Trust (LCRT) Commences 15M Common Stock IPO; Sees Pricng at $20/Share
-
LoanCore Realty Trust Announces Public Offering of Common Stock
-
LoanCore Realty Trust Announces Public Offering of Common Stock
-
Halozyme Therapeutics To Present At The JMP Securities 2015 Life Sciences Conference
-
Dicerna to Present at the JMP Securities Life Sciences Conference 2015
-
MINDBODY (MB) IPO Opens up 16%
-
Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
Cipher Pharmaceuticals to Present at 2015 JMP Securities Life Sciences Conference
-
Forward Pharma CFO to Present at the JMP Securities Life Sciences Conference
-
Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference
-
MINDBODY (MB) IPO Price at $14, Middle of Expected Range
-
MINDBODY Announces Pricing of Initial Public Offering
-
MINDBODY Announces Pricing of Initial Public Offering

